Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RCKT
RCKT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest RCKT ETF News Today | Earnings, Events & Price Alerts
RCKT News
Rocket Pharmaceuticals Q4 Earnings Beat Expectations
4d ago
seekingalpha
Overview of FDA Regulatory Developments
6d ago
NASDAQ.COM
Analysts Recommend Rocket Pharmaceuticals as a Top Buy
Feb 19 2026
Yahoo Finance
KBRA Assigns Ratings to $548.3 Million RCKT Mortgage Trust 2026-CES1
Jan 13 2026
Businesswire
Avant Technologies Strengthens Clinical Validation for α-Klotho Therapy
Dec 09 2025
PRnewswire
Avant Technologies Strengthens Clinical Validation of α-Klotho, Advancing Cell Therapy Progress
Dec 09 2025
Newsfilter
KBRA Assigns Ratings to $499.3 Million RCKT Mortgage Trust 2025-CES12
Dec 01 2025
Businesswire
Major Stocks Including Helmerich and Payne, Invivyd, and Home Depot Decline in Tuesday's Pre-Market Trading
Nov 18 2025
Benzinga
Rocket Pharmaceuticals, Inc. Reports Smaller Q3 Loss, Surpassing Expectations
Nov 06 2025
NASDAQ.COM
FDA's Strict Stance Creates Uncertainty for uniQure's Fast-Tracked Huntington's Gene Therapy
Nov 04 2025
Benzinga
ROCKET ALERT: Bragar Eagel & Squire, P.C. Investigates Rocket Pharmaceuticals, Inc. for Long-Term Stockholders and Urges Investors to Reach Out to the Firm
Oct 23 2025
Globenewswire
Rocket Pharmaceuticals retracts FDA review application for RP-L102
Oct 03 2025
SeekingAlpha
Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
Sep 19 2025
PRnewswire
FDA Details Steps to Accelerate Approvals for Rare Disease Treatments
Sep 04 2025
Benzinga
Rocket Pharmaceuticals reveals resignation of CFO
Aug 26 2025
SeekingAlpha
Thursday's Major Stock Market Highlights: Morning News Summary!
Aug 21 2025
TipRanks
Show More News
